Pure Global

Effect of Ginkgo Biloba Extract on Cognitive Function in Acute Ischemic Stroke - Trial NCT06140888

Access comprehensive clinical trial information for NCT06140888 through Pure Global AI's free database. This phase not specified trial is sponsored by Yi Yang and is currently Not yet recruiting. The study focuses on Acute Ischemic Stroke. Target enrollment is 356 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06140888
Not yet recruiting
drug
Trial Details
ClinicalTrials.gov • NCT06140888
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effect of Ginkgo Biloba Extract on Cognitive Function in Acute Ischemic Stroke
Effect of Ginkgo Biloba Extract on Cognitive Function in Acute Ischemic Stroke: a Multicentre, Randomised, Open-label, Blinded-Endpoint Trial

Study Focus

Acute Ischemic Stroke

Ginkgo Biloba Extract

Interventional

drug

Sponsor & Location

Yi Yang

The First Hospital of Jilin University

Timeline & Enrollment

N/A

Jan 01, 2024

Apr 01, 2027

356 participants

Primary Outcome

Changes of the Montreal Cognitive Assessment (MoCA) score

Summary

The purpose of this study is to determine the effect of ginkgo biloba extract on cognitive
 function in acute ischemic stroke.

ICD-10 Classifications

Stroke, not specified as haemorrhage or infarction
Sequelae of stroke, not specified as haemorrhage or infarction
Cerebral infarction
Cerebral infarction, unspecified
Transient cerebral ischaemic attack, unspecified

Data Source

ClinicalTrials.gov

NCT06140888

Non-Device Trial